Tosoh Bioscience Announces Scientific Committee for 10th HIC/ RPC Hydrophobic Bioprocessing Conference
News Jun 10, 2016
Tosoh Bioscience, the sole sponsor of this conference series, is pleased to announce the appointment of Dr. Todd Przybycien to the role of Scientific Chair. Dr. Przybycien is currently a professor of Chemical and Biomedical Engineering at Carnegie Mellon in Pittsburgh, PA, and has served with distinction on several other scientific committees.
“I’m honored to serve as Chair of the Scientific Committee for the 10th HIC/RPC Conference. We’ve assembled a terrific committee of widely respected experts in bioprocessing technology and applied biophysics to shape the technical program for the upcoming conference. We’re aiming to broaden the conference scope under the banner of “hydrophobic bioprocessing” – carrying on the strong reputation of the conference in hydrophobic and mixed-mode chromatography and in the modeling of hydrophobic interactions and extending it to include strategies for tuning hydrophobic interactions, exploitation of hydrophobic interactions in non-chromatographic unit operations (harvest, precipitation, extraction, filtration), biophysical characterization of host contaminant species, and the processing of biologics modalities among other topics. We’re looking forward to an excellent program.”
Dr. Przybycien will be joined on the Scientific Committee by the following distinguished scientists:
Ron Bates – Bristol-Myers Squibb, Syracuse, NY
Eggert Brekkan – GE Healthcare, Uppsala Sweden
Shekhar Garde – Rensselaer Polytechnic Institute, Troy, NY
Juergen Hubbuch – Karlsruhe Institute of Technology, Karlsruhe, Germany
Alois Jungbauer – University of Natural Resources and Life Sciences, Vienna, Austria
J. Kevin O’Donnell – Tosoh Bioscience LLC, King of Prussia, PA
Arne Staby – Novo Nordisk A/S, Gentofte, Denmark
Shuichi Yamamoto – Yamaguchi University, Yamaguchi, Japan
At this conference, the practical elements of hydrophobic bioprocessing development and implementation will be balanced by panel and individual discussions about novel approaches and theories. This combination will lead to a deeper understanding of the hydrophobic molecular interactions affecting selectivity and capacity, and the application of this knowledge to large scale processing of biomolecules.
Researchers have developed an artificial enzymatic pathway for synthesizing isoprenoids, or terpenes, in E. coli. This shorter, more efficient, cost-effective and customizable pathway transforms E. coli into a factory that can produce terpenes for use in everything from cancer drugs to biofuels.READ MORE
UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.READ MORE